Stock Events

Stock Events

Search...

Prelude Therapeutics (PRLD) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.47

-0.44

-0.4

-0.37

Details

Expected EPS

-0.4375

Actual EPS

-0.41

Surprise EPS

0.03

Surprise Percent

+6.29%

Description

Prelude Therapeutics (PRLD) has reported earnings of -0.41 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.